Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Half Year ended September 30, 2026 (Q2 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting under SEBI Listing Regulations

Audit Opinion:

Unmodified limited review reports issued by Statutory Auditors B S R and Co for both standalone and consolidated financial results.

Key Financial Highlights [Rs. in Millions]:

Consolidated Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹20,371.08 (QoQ: +8.4%, YoY: +21.3%)
  • Total Income: ₹20,576.51
  • Net Profit: ₹560.69 (QoQ: +69.0%, YoY: +1.0%)
  • EPS: Basic ₹4.73, Diluted ₹4.72
  • Profit before tax: ₹701.47
  • Tax Expense: ₹140.78
  • Total Comprehensive Income: ₹567.75

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹39,167.08 (YoY: +21.6%)
  • Total Income: ₹39,570.77
  • Net Profit: ₹892.36 (YoY: -8.8%)
  • EPS: Basic ₹7.49, Diluted ₹7.48
  • Profit before tax: ₹1,120.24
  • Tax Expense: ₹227.88
  • Total Comprehensive Income: ₹899.42

Consolidated Balance Sheet (as of September 30, 2026):

  • Total Assets: ₹41,978.29 million
  • Cash and Cash Equivalents: ₹1,453.43 million
  • Bank balances other than cash: ₹1,354.64 million
  • Total Equity: ₹20,675.56 million
  • Other Equity: ₹20,442.49 million
  • Total Liabilities: ₹21,302.73 million
  • Lease Liabilities: ₹15,489.56 million (Non-current: ₹13,355.51 million, Current: ₹2,134.05 million)

Standalone Results:

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹2,800.62 (QoQ: +25.8%, YoY: +36.2%)
  • Total Income: ₹2,841.05
  • Net Profit: ₹263.01 (QoQ: +50.7%, YoY: +68.2%)
  • EPS: Basic ₹2.19, Diluted ₹2.19
  • Profit before tax: ₹352.48
  • Tax Expense: ₹89.47
  • Total Comprehensive Income: ₹262.23

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹5,027.05
  • Total Income: ₹5,100.14
  • Net Profit: ₹437.52
  • EPS: Basic ₹3.64, Diluted ₹3.64
  • Profit before tax: ₹582.65
  • Tax Expense: ₹145.13
  • Total Comprehensive Income: ₹436.74

Standalone Balance Sheet (as of September 30, 2026):

  • Total Assets: ₹15,324.72 million
  • Cash and Cash Equivalents: ₹769.47 million
  • Bank balances other than cash: ₹482.45 million
  • Investments: ₹10,124.79 million
  • Total Equity: ₹13,627.83 million
  • Other Equity: ₹13,387.56 million
  • Total Liabilities: ₹1,696.89 million

Segment-wise Performance [Rs. in Millions]:

Quarter Ended September 30, 2026:

  • Retail Revenue: ₹19,957.68 (Segment Profit: ₹557.56)
  • Diagnostic Services Revenue: ₹410.54 (Segment Profit: ₹49.30)
  • Others Revenue: ₹2.86 (Segment Profit: ₹1.74)

Half Year Ended September 30, 2026:

  • Retail Revenue: ₹38,381.60 (Segment Profit: ₹873.19)
  • Diagnostic Services Revenue: ₹781.30 (Segment Profit: ₹72.54)
  • Others Revenue: ₹4.18 (Segment Profit: ₹1.40)

Corporate Actions:

  • Allotment of 19,095 Equity Shares under MedPlus Employees Stock Option Plan, 2021 to eligible employees of the Company/Group Company.

Other Significant Information:

  • Face value per share: ₹2.00
  • Paid-up equity share capital: ₹240.27 million
  • The financial results are available on company website (www.medplusindia.com) and stock exchange websites (www.bseindia.com, www.nseindia.com)